TAG

Results for: biobank

Finland has major competitive advantages for RWE research shows recent study conducted by MedEngine

Finland is in a good position to begin building a globally competitive ecosystem for real-world data (RWD) research, a qualitative survey conducted by MedEngine reveals. The survey was requested by the Pharma Industry Research Foundation and the results were presented at the Pharma Industry Finland Autumn meeting on November 21st, 2018. Real-world data and real-world… Read more »


Beyond treating patients: Secondary uses of health and social data

Whether it be an encounter with a physician or nurse, a prescription for medication from a pharmacy, or admittance of a student loan—every contact that we have with health care personnel or the social security system generates data related to our health and well-being. Currently, the Finnish Ministry of Social Affairs and Health is preparing… Read more »


Biobank Research – What’s in it for the Industry?

In March 2015, the Turku-based clinical biobank Auria became the first Finnish biobank to sign a collaboration contract with a global life science enterprise, Bayer Pharma AG. But this was just the beginning. In the past year, collaboration has been initiated between Finnish biobanks and several enterprises, including Roche, Pfizer, and MSD. International companies are… Read more »


CONTACT

MEDENGINE - BRIDGING
MEDICAL SCIENCE
WITH BUSINESS

GET IN TOUCH

029-1701101
info@medengine.fi

VISIT US

Eteläranta 14
00130 Helsinki
FINLAND


© 2019 MedEngine Oy